The myth of phenelzine acetylation.
作者信息
Marshall E F
出版信息
Br Med J. 1976 Oct 2;2(6039):817. doi: 10.1136/bmj.2.6039.817.
Abstract
摘要
相似文献
1
The myth of phenelzine acetylation.苯乙肼乙酰化的神话。
Br Med J. 1976 Oct 2;2(6039):817. doi: 10.1136/bmj.2.6039.817.
2
Metabolic acetylation of phenelzine in rats.大鼠体内苯乙肼的代谢乙酰化作用。
Res Commun Chem Pathol Pharmacol. 1988 Dec;62(3):397-406.
3
Metabolism and pharmacokinetics of phenelzine: lack of evidence for acetylation pathway in humans.苯乙肼的代谢与药代动力学：人类缺乏乙酰化途径的证据。
J Clin Psychopharmacol. 1985 Dec;5(6):333-7.
4
Acetylation of phenelzine.苯乙肼的乙酰化作用。
Psychopharmacology (Berl). 1979 Feb 28;60(3):261-3. doi: 10.1007/BF00426665.
5
Potential prodrugs of phenelzine: N2-acetylphenelzine and N2-ethoxycarbonylphenelzine.苯乙肼的潜在前药：N2-乙酰苯乙肼和N2-乙氧羰基苯乙肼。
J Pharm Sci. 1988 Jun;77(6):498-9. doi: 10.1002/jps.2600770607.
6
Microbial metabolism of phenelzine and pheniprazine.苯乙肼和苯异丙肼的微生物代谢
Life Sci. 1988;42(3):285-92. doi: 10.1016/0024-3205(88)90637-6.
7
Interaction of phenelzine and nitrazepam in a slow acetylator.苯乙肼与硝西泮在慢乙酰化者体内的相互作用。
Br J Clin Pharmacol. 1981 Aug;12(2):254-5. doi: 10.1111/j.1365-2125.1981.tb01212.x.
8
Acetylator status and response to phenelzine.乙酰化状态与对苯乙肼的反应。
Lancet. 1978 Nov 25;2(8100):1151-2. doi: 10.1016/s0140-6736(78)92307-3.
9
Polymorphic N-acetylation of phenelzine and monoacetylhydrazine by highly purified rabbit liver isoniazid N-acetyltransferase.
Drug Metab Dispos. 1982 May-Jun;10(3):225-9.
10
The relationship between response to phenelzine and acetylator status in depressed patients.抑郁症患者对苯乙肼的反应与乙酰化状态之间的关系。
Proc R Soc Med. 1973 Sep;66(9):947-9. doi: 10.1177/003591577306600959.
引用本文的文献
1
Phenelzine: acetylator status and clinical response.苯乙肼：乙酰化状态与临床反应。
Br J Clin Pharmacol. 1979 May;7(5):451-2. doi: 10.1111/j.1365-2125.1979.tb00985.x.
2
The influence of acetylator phenotype on the outcome of treatment with phenelzine, in a clinical trial.在一项临床试验中，乙酰化代谢表型对苯乙肼治疗结果的影响。
Br J Clin Pharmacol. 1978 Sep;6(3):247-54. doi: 10.1111/j.1365-2125.1978.tb04593.x.
3
Acetylation of phenelzine.苯乙肼的乙酰化作用。
Psychopharmacology (Berl). 1979 Feb 28;60(3):261-3. doi: 10.1007/BF00426665.
本文引用的文献
1
THE INFLUENCE OF ACETYLATOR PHENOTYPE ON THE EFFECTS OF TREATING DEPRESSION WITH PHENELZINE.乙酰化酶表型对苯乙肼治疗抑郁症效果的影响。
Clin Pharmacol Ther. 1965 Jul-Aug;6:430-5. doi: 10.1002/cpt196564430.
2
The monoamine oxidase catalyzed degradation of phenelzine-l-14C, an irreversible inhibitor of monoamine oxidase--II. Studies in vivo.
Biochem Pharmacol. 1969 May;18(5):1021-8. doi: 10.1016/0006-2952(69)90105-1.
3
Oxidation of 2-phenylethylhydrazine by monoamine oxidase.单胺氧化酶对2-苯乙肼的氧化作用。
Biochem Pharmacol. 1972 Jan 15;21(2):268-70. doi: 10.1016/0006-2952(72)90278-x.
4
The monoamine oxidase catalyzed degradation of phenelzine-l-14C, an irreversible inhibitor of monoamine oxidase--I. Studies in vitro.
Biochem Pharmacol. 1969 May;18(5):1011-20. doi: 10.1016/0006-2952(69)90104-x.
5
The relationship between acetylator status and inhibition of monoamine oxidase, excretion of free drug and antidepressant response in depressed patients on phenelzine.接受苯乙肼治疗的抑郁症患者中乙酰化状态与单胺氧化酶抑制、游离药物排泄及抗抑郁反应之间的关系。
Psychopharmacologia. 1976 Apr 15;46(3):289-94. doi: 10.1007/BF00421116.
Zotero 插件